These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

193 related items for PubMed ID: 7913267

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Impact of natural killer cells in mediating graft-versus-host disease following small bowel transplantation in a rat model.
    Fändrich F, Exner B, Papachrysanthou A, Jahnke T, Chambers WH, Zavazava N.
    Transplant Proc; 1996 Oct; 28(5):2465-6. PubMed ID: 8907904
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Histoincompatibility-associated differences in the phenotypes of murine cardiac allograft infiltrating T cells.
    Carlquist JF, Shelby J, Hammond EH, Greenwood JH, Anderson JL.
    Immunology; 1994 May; 82(1):149-53. PubMed ID: 7913913
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Immunologic changes in heterotopic and orthotopic small bowel transplantation in rats.
    Nakai T, Kawabe T, Kurooka K, Okuno K.
    Transplant Proc; 1999 Sep; 31(6):2661-4. PubMed ID: 10500761
    [No Abstract] [Full Text] [Related]

  • 10. Importance of lymphoid tissue for survival of small bowel allografts.
    Pirenne J, Williams JG, Kim S, Fryer J, Benedetti E, Hakim NS, Médot M, Najarian JS, Gruessner RW, Dunn DL.
    Transplant Proc; 1995 Feb; 27(1):1359-60. PubMed ID: 7878911
    [No Abstract] [Full Text] [Related]

  • 11. Ex vivo anti-CD3 antibody-activated donor T cells have a reduced ability to cause lethal murine graft-versus-host disease but retain their ability to facilitate alloengraftment.
    Drobyski WR, Majewski D, Ozker K, Hanson G.
    J Immunol; 1998 Sep 01; 161(5):2610-9. PubMed ID: 9725263
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. CD4+ T cells are both necessary and sufficient for islet xenograft rejection.
    Gill RG, Wolf L, Daniel D, Coulombe M.
    Transplant Proc; 1994 Jun 01; 26(3):1203. PubMed ID: 7913259
    [No Abstract] [Full Text] [Related]

  • 14. [CD4+, CD25+ regulatory T-lymphocytes: current concepts and therapeutic potential].
    Salomon B.
    J Soc Biol; 2002 Jun 01; 196(4):263-6. PubMed ID: 12645292
    [Abstract] [Full Text] [Related]

  • 15. Leflunomide immunosuppression in rat small intestinal transplantation.
    Foster PF, Xiao F, Kociss K, Chong AS, Sankary HN, McChesney L, Cohn S, Williams JW.
    Transplant Proc; 1994 Jun 01; 26(3):1599-600. PubMed ID: 8030053
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Fulminant graft-versus-host disease after FK 506 treatment in fully allogeneic small bowel transplantation.
    de Bruin RW, HogenEsch H, Heineman E, Jeekel J, Marquet RL.
    Transplant Proc; 1991 Dec 01; 23(6):3257-9. PubMed ID: 1721429
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.